Then, we selected BT-20 and HCC-38 as the MSL subgroup HER2-low TNBC cells, on the basis of the MSL scores, by analyzing the Genomics of Drug Sensitivity in Cancer database (Supplemental Figure 8G). The gene discussed is ERBB2; the disease is cancer.